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Abstract: 
Objective: To present pretreatment and post-treatment language data for a nonfluent aphasia 
patient who received 2 treatment modalities: (1) continuous positive airway pressure (CPAP) for 
his sleep apnea, starting 1-year poststroke; and (2) repetitive transcranial magnetic brain 
stimulation (TMS), starting 2 years poststroke. 
 Background: Language data were acquired beyond the spontaneous recovery period of 3 to 6 
months poststroke onset. CPAP restores adequate oxygen flow throughout all stages of sleep, 
and may improve cognition. A series of slow, 1 Hz repetitive TMS treatments to suppress a 
posterior portion of right pars triangularis has been shown to improve phrase length and naming 
in chronic nonfluent aphasia. 
 Method: The Boston Diagnostic Aphasia Examination and Boston Naming Test were 
administered pre-CPAP, and after 2 to 5 months of CPAP. These same tests were administered 
pre-TMS, and at 3 and 6 months post-TMS, and again 2.4 years later. 
 Results: Post-CPAP testing showed increased Phrase Length, Auditory Comprehension, and 
naming Animals and Tools/Implements (Boston Diagnostic Aphasia Examination). Testing at 3 
and 6 months post-TMS showed significant increase in Phrase Length, Auditory Comprehension, 
and Boston Naming Test compared with pre-TMS. These gains were retained at 2.4 years post-
TMS. CPAP use continued throughout. 
Conclusions: Physiologic treatment interventions may promote language recovery in chronic 
aphasia. 
Keyword: aphasia | CPAP | TMS | speech | language | stroke rehabilitation 
Article:  
Each year, there are approximately 80,000 new cases of adult aphasia due to stroke,1 and 50% to 
60% of cases continue to have chronic, communicative impairment.2,3 Approximately 20% have 
hesitant, poorly articulated, agrammatic speech with word-finding problems (nonfluent aphasia).4 
The relative role of neuroplasticity in the right hemisphere (RH), or in the left hemisphere (LH) 
in aphasia recovery remains unknown. In functional imaging studies with nonfluent aphasia, an 
increased, possible “overactivation” in RH frontal regions (inferior frontal gyrus, IFG; and motor 
cortex, M1) has been observed.5–9 This possible RH overactivation may be related to 
transcallosal disinhibition from the damaged, dominant LH, leading only to partial, or 
incomplete recovery. 
 Heiss and Thiel 10 have suggested that in long-term recovery, RH recruitment may be less 
efficient than restoring the LH network, where better recovery has been associated with higher 
activation in left superior temporal gyrus (STG) and left supplementary motor area.11,12 Recovery 
of naming has been associated with reperfusion of left Brodmann area (BA) 37, particularly in 
acute stroke cases studied with perfusion weighted imaging.13 Winhuisen et al 14 also observed as 
early as 2 weeks poststroke onset that better performance on a verbal fluency test (and better 
recovery) was associated with left IFG. After speech-language therapy with some chronic stroke 
patients, new LH activation has been associated with improvement in language.15–17 Richter et al 
18 have observed therapeutic success after treatment with constraint-induced aphasia therapy to 
be correlated with relative decrease of activation in RH areas, including the IFG/insular cortex. 
In some studies that included a variety of patients with aphasia, RH activation was considered to 
be compensatory.19–23 New RH activation has also been observed after speech-language therapy 
in patients with aphasia.23–26 Fernandez et al 27 suggested that RH participation in the acute 
recovery stage of LH stroke may be followed later, by LH activation corresponding to further 
recovery, and that the RH may play a larger role in supporting recovery when there is greater 
damage to LH language areas. Whether recovery in aphasia is mediated primarily from the LH, 
or from RH language homologs (or both), these studies suggest that there is potential for brain 
reorganization and improved language in poststroke aphasia.28 The underlying mechanisms 
remain elusive and there is need for additional treatment programs. 
This case report presents language data acquired from 6 months poststroke onset (MPO) to 4.6 
years poststroke, for a nonfluent aphasia patient who was treated with 2 physiologic treatment 
modalities beginning at 12.5 MPO: (1) continuous positive airway pressure (CPAP) to treat his 
sleep apnea; and (2) repetitive transcranial magnetic brain stimulation (rTMS), previously 
reported to improve phrase length and picture naming in patients with chronic nonfluent 
aphasia.29–31 
MATERIALS AND METHODS 
Participant 
The patient was a right-handed man who suffered a left middle cerebral artery embolic stroke at 
age 43. He received intravenous tissue plasminogen activator for the left middle cerebral artery 
clot with narrowing of the basilar artery. His history was significant for atrial septal defect that 
was repaired at age 9 with open heart surgery in Boston. He was born in Venezuela, premature in 
the seventh month, weighing 2 pounds (his twin died). He considered English his native 
language, but also spoke fluent Spanish. 
There was a residual right hemiparesis. He walked without a leg brace or a cane, and some finger 
flexion/spasticity was present. He was a graduate of a 2-year junior college and had been a 
grocery store manager. 
Structural Magnetic Resonance Imaging Scan and LH Lesion Sites 
 At 12 MPO, a 3-dimensional magnetization prepared rapid gradient echo (3D MPRAGE) 
magnetic resonance imaging (MRI) scan was obtained using a Siemens Vision 
Symphony/Quantum 1.5T scanner (field of view=256×256, 0.5 mm slice thickness, no gap; in 
plane resolution, 0.5×0.5 mm) (Figure 1). 
 
 Figure 1. A, Structural MRI scan (3-dimensional magnetization prepared rapid gradient echo) obtained 
at 1-year poststroke. Large cortical lesion was present in the left temporal lobe, including anterior 
portions of superior and middle temporal gyrus, with posterior extension across most of the middle 
temporal gyrus (BA 21). Only small lesion was present in the more anterior portion of Wernicke area. 
Small cortical lesion was present in only the most inferior portions of Broca area. The lesion was 
primarily subcortical in the 2 deep white matter areas near ventricle, associated with persistent nonfluent 
speech: (1) medial subcallosal fasciculus area, deep to Broca area and adjacent to frontal horn (vertical 
white arrows); and (2) periventricular white matter area adjacent to body of lateral ventricle, deep to 
sensori-motor mouth area (horizontal white arrow). B, Diagrams showing location, and some pathways 
within each of these 2 white matter areas adjacent to ventricle: (1) medial subcallosal fasciculus area 
adjacent to frontal horn, showing pathways from SMA and anterior cingulate gyrus to head of caudate 
(horizontal black arrow); and (2) periventricular white matter (PVWM) adjacent to body of lateral 
ventricle (vertical black arrow). Also see the text, where additional pathways are listed. BA indicates 
Brodmann area; MRI, magnetic resonance imaging; SMA, supplementary motor area.   
Most of the cortical lesion was in the left temporal lobe, where lesion included the anterior 
portion of the STG and middle temporal gyrus (MTG). The STG lesion included only a small, 
anterior portion of Wernicke area. This lesion was compatible with the potential for some 
recovery of auditory comprehension.32,33 Cortical lesion was also present in all of the left MTG 
(BA 21), including the superior temporal sulcus. In the left frontal lobe, small cortical lesion was 
present in only the most inferior part of Broca area, and the sensory cortex area. No cortical 
lesion was present in the left supramarginal or angular gyrus areas. The lesion was primarily 
subcortical, centered over the putamen, with deep anterior and superior white matter lesion 
extension, near ventricle. Lesion in these deep white matter areas is associated with persistent 
nonfluent speech,34,35 which otherwise would not be expected in a patient with primarily only 
temporal lobe lesion. These 2 areas are: (1) the medial subcallosal fasciculus (MScF) area, deep 
to Broca area and located adjacent to the left frontal horn; and (2) the middle one-third 
periventricular white matter (PVWM) area, deep to the sensorimotor cortex area for mouth and 
located adjacent to body of caudate and body of the lateral ventricle. The MScF includes 
pathways from the supplementary motor area and the anterior cingulate gyrus area (BA 24) to 
head of the caudate, and these fibers may play a role in part, for the initiation of speech output. 
The PVWM area contains afferent and efferent pathways for mouth (and upper and lower limb), 
thalamo-cortical, callosal, and occipito-frontal pathways; and these fibers may play a role in part, 
for motor-sensory aspects of speech production. Because this patient had lesion in less than half 
of the MScF and lesion in about half of the PVWM, there was potential for recovery of a longer 
phrase length. The right hemiparesis was likely associated with lesion in the PVWM, because 
there was no lesion in the posterior limb, internal capsule, or motor cortex. (Due to the presence 
of metal staples in the sternum, a 3T overt naming functional MRI scan could not be performed.) 
Two Treatment Modalities 
 CPAP 
At 6 MPO, when the patient was evaluated by the neurologist (R.K.), he displayed excessive 
sleepiness and fatigue. Later, after a sleep study, he was diagnosed with obstructive sleep apnea 
(OSA). CPAP, delivered by face mask throughout the night, has demonstrated benefit for the 
majority of those with mild to moderate sleep apnea.36 CPAP is continuous, to provide constant 
pressure, and it is positive, to prevent airway collapse, thus ensuring adequate oxygen flow 
throughout all stages of sleep.37 If left untreated, OSA can be associated with higher incidence of 
hypertension, myocardial arrhythmias, coronary artery, and cerebovascular disease; inadequate 
sleep has been linked to poor cognitive performance and increased rates of accidents.38 
The patient began CPAP at 12.5 MPO, which is beyond the 3 to 6-month poststroke time period 
when most spontaneous recovery has occurred.39 Although CPAP was prescribed for medical 
reasons, and not planned as a treatment modality for aphasia, some limited language testing was 
available pre-CPAP at 6 to 8 MPO and at 12 MPO. After 2 to 5 months of CPAP, language 
testing was performed 3 times (14-17 MPO). The post-CPAP testing was performed as part of 
baseline language testing before TMS treatment. Language testing included the Boston 
Diagnostic Aphasia Examination (BDAE) and the Boston Naming Test (BNT).40–42 (Table 1) 
He had received speech-language therapy only before 12 MPO; not during or after CPAP or 
TMS. 
Table 1. Language Test Scores Pre-CPAP and Post-CPAP and TMS Treatments Boston 
Diagnostic Aphasia Examination (BDAE, 3rd ed., 2001; and 2nd ed., 1983, Auditory 
Comprehension Subtests Only) and Boston Naming Test (first 20 pictures) 
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Results After 2 to 5 Months of CPAP 
Post-CPAP, there was improvement in Phrase Length, Auditory Comprehension, and some 
picture naming (BDAE). On pre-CPAP testing (6-8 MPO and 12 MPO), the longest phrase 
length on the BDAE cookie theft picture description was 2 to 4 words (eg, “she's cookies”). Post-
CPAP, across the 3 testings (14-17 MPO), the mean longest phrase length was 5 words (range, 4-
6 words)–for example, at testing one, the longest phrase length was 6 words: “she let it go with 
water;” at testing two, 4 words: “he got cookie jugs;” and at testing three, 5 words: “gave her and 
him some.” 
An area of major improvement post-CPAP was Auditory Comprehension (Table 1). Pre-CPAP, 
the Word Discrimination scores were 52 and 60/72; and post-CPAP, the mean across 3 testings 
was 66.3. For Body Part Identification, pre-CPAP the scores were 12 and 10/20; and post-CPAP, 
13.33. For Commands, pre-CPAP, the scores were 6 and 7/15; and post-CPAP, 10.67. 
Improvement was also observed post-CPAP on the BDAE subtests for naming Animals, and 
Tools/Implements. Pre-CPAP, the naming score for Animals was 5/12; and post-CPAP, 8. Pre-
CPAP, the naming score for Tools/Implements was 2/12; and post-CPAP, 5.67. It is not possible 
to know if these changes were significant post-CPAP, due to limited testing, pre-CPAP. 
rTMS 
As reviewed in the Introduction, functional imaging studies with nonfluent aphasia have 
observed unusually high, possible “overactivation,” in parts of right Broca area and other right 
perisylvian language homologs during language tasks; this may represent maladaptive 
plasticity.5–9 Repetitive TMS allows painless, noninvasive stimulation of human cortex 
(approximately 1 cm3 in size) from outside of the skull. Slow (1 Hz) rTMS decreases excitability 
in the targeted cortical region of interest (ROI)43,44 that lasts beyond the duration of the train 
itself,45 leading to measurable behavioral effects. Conversely, rapid rTMS (>=5 Hz) increases 
cortical excitability.45 
In our TMS research with chronic nonfluent aphasia patients, we hypothesized that suppression 
of activity in a targeted RH ROI with slow, 1 Hz rTMS would have an overall modulating effect 
on functionally connected elements of the distributed neural network for speech and 
language.29–31 We have observed at 2 months after 10 rTMS treatments applied to right 
posterior-inferior pars triangularis (PTr), there was significant improvement on 3 naming tests: 
(1) the BNT, first 20 items (P=0.003); (2) the BDAE subtest, naming Animals (P=0.02); and (3) 
the BDAE subtest, naming Tools/Implements (P=0.04).31 At 8 months post-rTMS, all 3 naming 
test scores continued to improve relative to pre-rTMS testing, but only Tools/Implements was 
significant (P=0.003). None of the 4 patients received any individual speech therapy during or in 
the 8-month follow-up testing of the TMS study. 
rTMS Treatment Protocol in this Case 
The patient continued to use CPAP throughout the study (and to date). He signed informed 
consent forms approved by institutional review boards at all the 3 institutions where this research 
took place.   
Baseline Snodgrass and Vanderwart (S&V) Naming Ability 
Before any rTMS, a baseline naming ability for Snodgrass and Vanderwart 46 (S&V) pictures 
was established. This baseline S&V naming score was later used during phase 1 TMS sessions 
(explained below) to help establish the best RH cortical ROI to suppress with rTMS, to improve 
picture naming. During the baseline S&V naming testing, ten, 20-item S&V picture lists were 
administered across separate testing sessions. His baseline mean S&V naming score was 9.6 
(SD=2.67). The TMS treatment protocol consisted of 2 phases. 
Phase 1 of TMS 
During phase 1 of TMS, a best-response RH cortical ROI was located, which would later 
become the targeted location for TMS during phase 2. During phase 1, the effect of slow, 1 Hz 
rTMS for 10 min to suppress activity in each of the 5 different RH frontal regions was examined 
across separate visits. In this case, the phase 1 visits took place over a 10-month period, due to 
scheduling issues. Normally, these visits would take place within a few weeks before the first 
phase 2 rTMS treatment. 
 During phase 1, a total of 600 pulses (90% of motor threshold for the left first dorsal interosseus 
muscle) were delivered to each RH ROI using the Super-Rapid High Frequency MagStim 
Magnetic Stimulator (MagStim, NY). A figure-8 shaped rTMS coil with a 7 cm outside diameter 
on each wing was used. This allowed direct stimulation of an area that was about 1×1 cm. The 
interactive frameless stereotaxic system (Brainsight, Rogue Industries, Montreal) was used with 
the patient's 3D MPRAGE MRI scan to guide the position of the rTMS coil on the patient's 
scalp; the coil was held constant across sessions, at approximately 45 degrees. The location of 
the 5 right frontal ROIs studied during phase 1 are shown in Figure 2. These 5 ROIs included the 
right M1, mouth (orbicularis oris muscle, as verified with motor evoked potential), and 4 
subregions within right Broca area. Each of the 5 RH ROIs was suppressed once, in separate 
sessions; and later, PTr posterior and PTr middle, were each suppressed again (similar results 
were obtained). 
 
Figure 2. Location of the 5 frontal ROIs that were each suppressed with 1 Hz rTMS for 10 minutes 
during phase 1 TMS, to determine the best-response ROI. These 5 ROIs included right M1, mouth 
(orbicularis oris muscle, as verified with MEP), and 4 subregions within right Broca area as defined in the 
text, using sulcal boundaries (arrows). The gyral location for each ROI that was suppressed with rTMS is 
marked in color, see legend box. The legend box also shows the number of Snodgrass and Vanderwart 
(S&V) pictures (max=20) named immediately after rTMS suppression of each ROI. The PTr posterior 
ROI (green symbol), was the best-response ROI—for example, the area associated with a naming score 
that reached at least 2 SD above baseline S&V naming ability (eg, 15). Note that the number of pictures 
named correctly immediately post-rTMS decreased for any given ROI as the distance from the best-
response ROI increased by 1 or 2 cm, in a rostral or caudal direction. The PTr posterior ROI (green 
symbol) was used as the target for suppression with 1 Hz rTMS for ten, 20-minute treatments during 
phase 2 TMS. M1 indicates motor cortex; MEP, motor evoked potential; POp, pars opercularis; PTr, pars 
triangularis; ROI, region of interest; rTMS, repetitive transcranial magnetic brain stimulation. 
The subregions within right Broca area on the patient's 3D MPRAGE MRI scan were labeled 
according to sulcal and gyral boundaries as defined by Amunts et al.47,48 Broca area is classically 
defined as the pars triangularis (PTr) and pars opercularis (POp) portions of the IFG, and these 
parts are often considered to correspond in a general manner with the cytoarchitectonic BAs 45 
and 44, respectively. We are aware that without cytoarchitectonics, the issue of which anatomic 
landmark (sulcus) to use as a dividing marker between PTr and POp is not straightforward, 
especially when a diagonal sulcus (DS) is present, as it was in this case in the RH. When present, 
the DS is located caudal to the vertical ascending ramus and rostral to the inferior precentral 
sulcus. When this occurs, an “extra gyrus” within the posterior portion of the IFG is present. 
Amunts et al 47,48 examined 10 brains (20 hemispheres) both with surface anatomy, and with 
cytoarchitectonics. They observed large variation across the brains, and when a DS was present 
(occurring only in every second hemisphere), the DS could either mark the border between BA 
45 and 44, or it could be inside BA 44. Thus, without cytoarchitectonics in the present study, it 
was not possible to know whether the DS was a border between PTr and POp, or if it was within 
the POp. 
Taking the results of Amunts et al 47,48 into consideration for this case study, we arbitrarily chose 
to use the DS as the dividing marker between the POp and the PTr. The 4 subregions within right 
Broca area (each about 1 cm apart) were defined as follows: (1) POp: gyrus that is rostral to the 
inferior precentral sulcus and caudal to the DS; (2) PTr posterior: gyrus that is rostral to the DS 
and caudal to the vertical ascending ramus; (3) PTr middle: gyrus that is rostral to the vertical 
ascending ramus and caudal to the triangular sulcus; (4) PTr anterior: gyrus that is rostral to the 
triangular sulcus and caudal to the horizontal ramus (Figure 2). 
Before and after each 10-minute rTMS application to a specific RH ROI, a 20-item S&V set of 
pictures was presented for the patient to name. The best-response cortical ROI was defined as the 
ROI that was associated with an S&V naming score, at least 2 SD above the baseline mean S&V 
naming score. In this case, the S&V naming score after 10 minutes of rTMS to a RH ROI needed 
to reach at least 15 pictures named correctly (9.6+5.34=14.94), to meet the criterion for best-
response RH ROI (baseline mean was 9.6; SD=2.67). The best-response RH ROI in this case 
was the gyrus located rostral to the DS and caudal to the vertical ascending ramus—for example, 
right PTr posterior, in Figure 2. Figure 3 shows in bar graphs, the percent change from baseline 
for S&V pictures named correctly after 10 minutes of rTMS to suppress each of the 5 RH ROIs; 
the percent change in response time is also shown. 
 
Figure 3. A, Bar graph showing the percent change from baseline, for S&V pictures named 
correctly after 10 minutes of rTMS to suppress each of the 5 RH ROIs during phase 1 TMS. B, 
Bar graph showing the percent change from baseline for RT to name the pictures, for each of the 
5 RH ROIs. Note, the PTr posterior ROI was associated with the greatest improvement in 
number of pictures named on 2 occasions. PTr indicates pars triangularis; RH, right hemisphere; 
ROI, region of interest RT, response time; rTMS, repetitive transcranial magnetic brain 
stimulation; S&V, Snodgrass and Vanderwart.   
Figures 2 and 3 show that when a targeted ROI is located further away from the best-response 
ROI, naming accuracy decreases. The highest post-rTMS naming scores of 14 and 15 were 
obtained when right PTr posterior was suppressed (2 separate rTMS sessions). When the coil 
was positioned 1 cm rostral to the PTr posterior, for example, on the PTr middle, scores of only 
10 or 11 were obtained. When the coil was positioned 1 cm caudal to PTr posterior, for example, 
on the POp, the score of 12 was obtained. 
The naming scores were even lower, when the coil was positioned 2 cm rostral to the best-
response ROI, for example, on the right PTr anterior (8 pictures named); or 2 cm caudal to best-
response ROI, on the M1 mouth (9 pictures named). These scores show that the location of the 
best-response ROI in this case was precise, for example, the right PTr posterior. These phase 1 
data emphasize the importance of testing the effect of rTMS to suppress several ROIs to 
establish the location of a best-response ROI. 
Phase 2 of TMS 
 During phase 2, the best-response RH ROI from phase 1 was suppressed for a longer treatment 
time (20 min), and over more days (5 days a wk, for 2 wk). At 27 MPO, this patient received ten, 
20-minute rTMS treatments to suppress the right PTr posterior, as shown in Figure 2. On each 
day of treatment, the rTMS was applied at 1 Hz frequency for 20 minutes (1200 pulses) at 90% 
of motor threshold (left first dorsal interosseus muscle), as tested each day before treatment. The 
same equipment used in phase 1, was used in phase 2. Our rTMS parameters are similar to those 
used in various studies where multiple rTMS treatments were given over time, to help treat 
depression.49–51 No negative side effects have been reported with these parameters. 
Language testing was performed at 3 and 6 months post-phase 2 TMS, and again at 2.4 years 
later. At the longest time post-TMS, testing was performed 3 times, 4 days apart each time. 
Results After TMS Treatments 
Significant improvements were observed on Phrase Length for the BDAE cookie theft picture 
description and naming pictures (BNT) at 3 and 6 months post-phase 2 TMS; these significant 
gains remained stable at 2.4 years post-TMS. There was also significant improvement on 2 
Auditory Comprehension subtests, Body Part Identification and Commands, at 6 months post-
rTMS and at 2.4 years (Table 1). 
On the BDAE cookie theft picture description, the pre-TMS baseline mean for longest phrase 
length was 5 words; and at 3 and 6 months post-TMS, it was 11 and 7 words, respectively. The 
11-word phrase length at 3 months post-TMS was, “his mother wash the dish up and the water 
fall down.” At 6 months post-TMS the longest phrase was, “his mother was watching the paper 
plates.” At 2.4 years post-TMS, the longest phrase length at each of the 3 testing times was 6, 9, 
and 12 words—for example, 6 words: “the mother was washing some dishes;” 9 words: “water 
was falling off the sink to the floor;” and 12 words: “she was getting her cookie jars and she 
started to fall back.” The complexity of his phrases, as well as the length, increased. The BNT 
score improved from a mean of 8.67 pictures named at baseline to 12 and 13 named at 3 and 6 
months post-TMS. These gains in naming were stable at 2.4 years post-TMS, with scores of 15, 
13, and 15, at the 3 testing times. 
DISCUSSION 
 This case report documented language improvement after each of the 2 treatment modalities 
applied later than 1-year poststroke onset, in a patient with nonfluent aphasia. The patient started 
using the first treatment modality, CPAP, for sleep apnea beginning around 12.5 MPO. After 2 to 
5 months of CPAP use, there was improved Phrase Length, Auditory Comprehension, and 
naming of Animals and Tools/Implements. The patient began treatment with the second 
modality, TMS, at 27 MPO. At 3 and 6 months as well as at 2.4 years post-TMS, there was 
significant improvement (P<0.05, or 2 SD above pre-TMS baseline mean) in Phrase Length and 
the BNT. There was significant improvement at 6 months and 2.4 years post-TMS on 2 subtests 
of BDAE Auditory Comprehension. 
Some areas of language improvement post-CPAP and post-TMS were similar, and some were 
unique to 1 treatment modality. For example, post-CPAP, a major area of improvement was in 
Auditory Comprehension (Word Discrimination, Body Part Identification, and Commands). Our 
prior TMS studies with aphasia patients have not observed improvement in Auditory 
Comprehension testing, post-TMS. In this case, however, there was additional significant 
improvement in Auditory Comprehension for Body Part Identification and Commands, post-
TMS at 6 months and 2.4 years later. Post-CPAP, there were also areas of improvement that 
overlapped with areas of improvement seen in our previous TMS studies— for example, Phrase 
Length and naming Animals and Tools/Implements.29–31 
In addition to improvement in Phrase Length post-TMS, an area of significant improvement that 
paralleled results from our previous TMS studies was naming pictures on the BNT. At 3 and 6 
months post-TMS, this patient had BNT scores of 12 and 13. His baseline mean on this test was 
8.67 (SD, 1.41; +2 SD=11.50). This significant gain on the BNT was retained at 2.4 years post-
TMS, with scores of 13 to 15. 
In this case, there was no additional improvement post-TMS on naming Animals or 
Tools/Implements, whereas significant improvement in these 2 naming areas had been observed 
in our previous TMS studies.30,31 There had been improvement in naming Animals and 
Tools/Implements post-CPAP, however, in this case. 
To our knowledge, there are no previous reports on the effect of CPAP on language behavior in 
stroke patients with aphasia who have sleep apnea. CPAP is a treatment applied for sleep apnea, 
and although it is not comparable to hyperbaric oxygen treatment in stroke patients (without 
sleep apnea), they each might have a potential overall effect on cerebral circulation and 
oxygenation. Sarno et al 52 studied the effect of a single hyperbaric oxygen treatment (100% 
oxygen at 2 atmospheres of pressure) on a group of 16 patients with aphasia. There was no 
significant effect on language, as tested immediately after the 1.5-hour treatment. In contrast, in 
the present study, CPAP was used almost nightly, for 2 to 5 months, after which, language was 
again tested. 
The specific effect of nightly CPAP use on cortex and brain activation is unknown without 
functional MRI, which could not be performed in this case. CPAP may have had a more general, 
overall cortical effect, including improved oxygenation to spared areas of left temporal lobe. 
Improvement was observed in Auditory Comprehension after CPAP use. This patient spared at 
least half of the left STG (Wernicke area), which has been associated with potential for 
improvement in Auditory Comprehension.32,33 
There was also improvement in naming Animals and Tools/Implements, post-CPAP. Naming 
ability in these categories has been associated with activation in the mesial occipital cortices and 
middle infero-temporal areas (animals), and posterior infero-temporal areas and anterior regions 
of the supramarginal gyrus (tools).53 This patient had also spared these regions of the left 
temporo-parietal cortex, and perhaps the repeated use of CPAP mediated some of these temporo-
parietal networks associated with naming Animals and Tools/Implements. 
The TMS treatments may have been more specific, primarily affecting neural networks 
associated more with speech output (vs. Auditory Comprehension), including Phrase Length and 
Naming (BNT). During the 10 rTMS treatments in phase 2, there was suppression of a specific 
part of right IFG—for example, right PTr posterior. Suppression of this area was hypothesized to 
reduce the effect of transcallosal disinhibition from the damaged LH on right PTr and thus 
reducing overactivation of right PTr (and likely exaggerated inhibition of right POp from right 
PTr posterior, via U-fibers) and in turn, promote better modulation of right POp and the bi-
hemispheric neural network for speech and naming. 
Components of this neural network in the LH, as reviewed by Gold and Buckner 54 include in 
part, connections from left inferior prefrontal cortex to left BA 21 (for semantic processing); and 
connections from left inferior prefrontal cortex to an area near precentral left BA 6 and inferior 
parietal (left BA 40) (for phonologic processing). Although this patient did have lesion in most 
of left BA 21 (left MTG), there was no lesion in most of the other components of this neural 
network in the LH. Thus, whereas speech output did not become entirely normal in this patient 
post-TMS, there was apparently enough of this neural network remaining that could become 
active, to enable this patient to have significant improvement in at least 2 subtests requiring 
speech output—for example, (1) Phrase Length; and (2) the BNT. Post-CPAP, the patient had 
also shown improvement in aspects of speech output, for example, in Phrase Length, as well as 
in naming, although specific to BDAE Animals and Tools/Implements, not BNT. 
The new, unique improvement post-CPAP had been in Auditory Comprehension, including 
Word Discrimination, Body Part Identification, and Commands. There was additional, 
significant improvement in Body Part Identification and Commands, at 6 months post-TMS, and 
this was retained at 2.4 years post-TMS. The patient continued to use CPAP, most nights, even 
out to 2.4 years post-TMS. 
The overall positive response for language improvement in this patient after CPAP and TMS is 
encouraging. The use of both treatment modalities in this case suggests that the neural networks 
for several aspects of speech and language remain accessible in the chronic stage, poststroke 
onset. It is likely there are additional physiologic interventions that could access this 
neuroplasticity. 
Another physiologic intervention that holds promise for improvement in patients with chronic 
aphasia includes transcranial direct current stimulation (tDCS) (cathodal to the left fronto-
temporal area).55 Although the effect of only 1 session was examined, improved naming was 
observed with an increase of 33.6% (SEM 13.8%) in 8 chronic nonfluent aphasia patients. 
Multiple tDCS sessions and the long-term language effects have not been reported. 
The effect of high-frequency rTMS on naming Actions and Objects in mild and moderate-to-
severe Alzheimer disease (AD) has been recently studied.56 The 20 Hz rTMS was applied to the 
left or to the right dorsolateral prefrontal cortex areas, for 500 msec while the subject was asked 
to name a picture on the screen. The mild cases showed significant improvement in naming 
Actions only; whereas the moderate-to-severe cases showed improvement in naming Actions and 
Objects. CPAP has been used to treat OSA in patients with AD, where comparison of 
pretreatment and post-treatment neuropsychologic test scores after 3 weeks of therapeutic CPAP 
showed significant improvement in cognition.57 
Results from these studies are similar to the present study, because they suggest a neural 
plasticity is present in chronic aphasia (and AD). Physiologic intervention with CPAP (when 
OSA is present), and/or either slow or fast rTMS, or tDCS, when placed on the proper cortical 
target area with specific treatment parameters, can induce improvement in many aspects of 
language behavior. 
Limitations of this Case Study 
 Limitations to this case report include: (1) It is unknown if the language improvements post-
CPAP alone, were significant, because the patient was only tested twice, before CPAP treatment. 
(2) It is unknown if the improvement post-CPAP had plateaued after 2 to 5 months of use. The 3 
testings over a 3-month period (at 14-17 MPO) after 2 to 5 months of CPAP use suggested 
stability in the language scores. However, it is not possible to know, if continued use of CPAP 
alone, and no intervention of TMS, would have yielded the same improvements in language 
behavior. (3) The relative contribution of rTMS to the significantly improved language scores 
post-TMS is also unknown, because the patient continued to use the CPAP mask, most nights, 
throughout the rTMS treatment periods and this continues to date. It is possible there was a 
synergistic contribution from each intervention, but this also is unknown.  
Despite these limitations, results from the present study reinforce results from our previous TMS 
studies—for example, improvement in Phrase Length, and picture-naming on the BNT after 
suppression of a posterior portion of right PTr (gyrus located immediately anterior to right POp) 
with 1 Hz rTMS.29–31 These TMS results also support the notion behind “paradoxical 
functional facilitation,”58 where a new, temporary “virtual” lesion (as with 1 Hz rTMS) or a new 
real lesion (as with a second stroke in a specific location), can improve behavior in chronic 
stroke. For example, Vuilleumier et al59 have reported the disappearance of left-sided neglect in a 
stroke patient with a right parietal infarct, after the appearance of a new left frontal lobe lesion. 
There are also case studies where ambidextrous adults who had stuttered since childhood no 
longer stuttered, after unilateral brain damage in adulthood (eg, stroke or head injury), even as 
soon as 10 days postonset.60 
Additional studies with single, or multiple physiologic interventions—for example, low-
frequency or high-frequency rTMS, tDCS, and even hyperbaric oxygen could all be considered. 
Recently, transcranial, infrared laser therapy was observed to significantly improve stroke 
outcome at 90 days (NIH Stroke Severity Scale), when applied once around 18 hours poststroke 
onset.61 With the exception of the rTMS protocol presented here (and in our previous TMS 
papers), these other studies with physiologic interventions have applied only a single session of 
treatment. It is suggested that more treatment sessions be applied over longer periods of time. 
Also, the combination of a physiologic intervention with speech therapy sessions provided 
immediately afterwards, might promote further language improvement in a variety of chronic 
aphasia patients.   
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